Paradoxical increase in uric acid level with allopurinol use in pyrazinamide-induced hyperuricaemia
Vedat Gerdan1, Nurullah Akkoc, Eyup Sabri Ucan
1Department of Internal Medicine, Dokuz Eylul University School of Medicine, Izmir, Turkey.
Abstract:
We report the case of a 36-year-old man with psoriatic arthritis and miliary tuberculosis, whose serum uric acid (SUA) level increased after the initiation of antituberculosis treatment, which included pyrazinamide. Most strikingly and paradoxically, the patient's SUA level increased after treatment with allopurinol. On cessation of allopurinol, his SUA level decreased substantially, and complete normalisation was observed following the discontinuation of pyrazinamide treatment.
Related Concept Videos
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Drug toxicity: Drug–Drug Interaction
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Urinary Tract Calculi III: Medical Management
Pharmacokinetics: Drug–Drug Interactions
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)